Octreotide Acetate
Octreotide Acetate (Sandostatin) is a synthetic somatostatin analogue used to treat metastatic carcinoid tumors, VIP-secretory tumors, and acromegaly. It selectively inhibits growth hormone, glucagon, and insulin secretion with longer-lasting effects than natural somatostatin.

Description
Product Introduction
Octreotide belongs to digestive system drugs, which is an artificially synthetic cyclic octapeptide compound, and is a homolog of natural somatostatin. It contains the pharmacological activity of a natural somatostatin, and has long-lasting effects (the half-lifetime of this product is 1.5 hours, while it is 2 to 3 minutes for natural somatostatin). The product selectively inhibits the secretion of growth hormone, glucagon and insulin, and the effect is stronger than natural.
Application
Octreotide acetate (Sandostatin) is used to treat metastatic carcinoid tumors, vasoactive intestinal peptide-secretory tumors, also used in treatment of acromegaly. Octreotide (Sandostatin) is a synthetic somatostatin analogue; it can be produced by two methods: fragment condensation solution phase procedures and solid-phase procedures.
Product Description
- Application Field
- Endocrine therapy, acromegaly, neuroendocrine tumors, peptide drug API
- Packaging
- Custom packaging per client requirements
- Storage Conditions
- -20°C, protected from light, sealed storage
- Shelf Life
- 2 years
Specifications
| Appearance | White to off-white powder |
| Purity (HPLC) | ≥98% |




